Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-810215
  • Global InVitro Fertilization (Ivf) Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: January 2016 | Report Code: HPH-810215

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

In Vitro fertilization involves a series of complex procedures that are utilized in the treatment of fertility and genetic problems. In this process, mature eggs that are collected from the ovaries are fertilized with the help of sperm in the laboratory. The global in Vitro fertilization market is anticipated to rise with a CAGR of about 6.1% during the forecast years 2016-2023. Faster egg freezing techniques such as vitrification are largely trending in the market. Earlier due to slow freezing technologies, the survival rate of embryo was around 70%. Due to vitrification technique survival rate of embryo increased to about 98%. 

The expensive procedures and legal issue related with the in-vitro fertilization procedure is hampering the growth of the global in-vitro fertilization market.   The increasing demand for low cost instruments and drugs for in-vitro fertilization and increasing investment from private equity investors is creating huge opportunities in the forecast period for the global in-vitro fertilization market.

The in-vitro fertilization permits procurement of medical aids by deliberated practice rather than an apprentice practice. In-vitro fertilization technique helps to enhance medical proficiency. The rising infertility rate is driving the growth of the in-vitro fertilization market. The increasing infertility rate is also giving rise to the fertility tourism in the emerging markets due to low cost and success rate of surgeries and treatments in such regions. In 2014, 10% of the women aged 20-44 suffer from infertility. According to WHO in 2015, 6.7 million women aged 15-44 in the world were suffering from infertility. Thus, the rising infertility rate is driving the global in-vitro fertilization market. The adoption of global in-vitro fertilization market is driven by:

  • Rise in Infertility 
  • Fertility Tourism 
  • Surrogacy Also Responsible for Fertility Tourism 
  • Technological Advancement in Healthcare Domain 
  • Increase in Success Rate of Treatments 
  • Increasing Acceptance of Donor Eggs by Consumers







Source: OBRC Analysis

The in-vitro fertilization is segmented on the basis of product, technology and end-user.

On the basis of product, market is segmented into:

  • Reagents
  • Equipments



On the basis of technology, market is segmented into:  

  • Intra-Cytoplasmic Sperm Injection (icsi)
  • Pre-Implantation Genetic Diagnosis (pgd)
  • Frozen Embryo Transfer/Replacement (fet/fer)
  • Others





On the basis of end-user, market is segmented into:  

  • Fertility and Surgical Centers
  • Hospitals and Research Laboratories
  • Cryobanks




On the basis of product, in-vitro fertilization market is segmented in to reagents and equipments. Reagents is further segmented in to embryo culture media, cryopreservation media, sperm processing media and ovum processing media. equipmet is further segmented in to imaging system, sperm separation system, cabinets, ovum aspiration system, incubators, micromanipulators system, gas analyzers, laser system, cryosystems, cryosystems, anti-vibrant tables and accessories.  Technology segment is further segmented in to intra cytoplasmic sperm injection, preimplant genetic diagnosis, frozen embryo transfer/ replacementand other.  intra cytoplasmic sperm injection is fastest growing technology segment. on the basis of end-user, in-vitro fertilization market is segmented in to fertility and surgical centers, hospitals and research laboratories and cryobanks.  the fertility and surgical centers segment contributed to largest market shar of the global in-vitro fertilization market.

The revenue for the above end-user segments are specific to the in-vitro fertilization market. however, the total revenue of these end-users in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up technology segment. Geographically, the global in-vitro fertilization market has been segmented on the basis of four major region, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America dominates the in-vitro fertilization market by the presence of some big key players such as Auxogyn Inc., Ova Science and Irvine Scientific Inc. The companies are doing technological innovations, and mergers and acquisition which is increasing the market share of the key players. The high growth in Asia Pacific countries is driven by the increasing awareness, rising support for women health, and growing medical tourism in the region. The major countries in this region are China, India, Japan and Australia.

The major market players of the global in-vitro fertilization market are:

  • Vitrolife AB
  • Irvine Scientific Inc.
  • GeneaBiomedx
  • Cooper Surgical. Inc.
  • Auxogyn Inc.,
  • Origoand Ova Science







Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

Mergers, acquisitions, innovations, and product development are the key strategies adopted by key players to sustain in the competitive market. On January 07, 2016, the Irvine Scientific Inc. acquired BioCare Europe S.R.L. of Italy. This acquisition is aimed to expand the market in the European region.

Why to buy the report:

This report will provide you:

  • Provide you the business strategies adopted by market player such as acquisition. On January 07, 2016, the Irvine Scientific Inc. acquired BioCare Europe S.R.L. of Italy. This acquisition is aimed to expand the market in the European region
  • Provide in detail the different segments such as male infertility and female infertility which are affecting the global in-vitro fertilization market.
  • Provide you the patent analysis of the in-vitro fertilization market.
  • Identify, understand, and the strength, opportunities, challenges and threat of the in-vitro fertilization market.
  • Provide revenues of major players of the market such as Irvine Scientific Inc., GeneaBiomedx.  
  • Provide you various the regulatory policies which are affecting the global in-vitro fertilization market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global in-vitro fertilization market offers the longest chain of market segmentation covering major market segmentation based on technology and end users. Report tracks the major market trends in the global in-vitro fertilization such as increasing adoption of surrogacy techniques, success rate of advanced invitro fertilization and so on.   For each market segments covered in global in-vitro fertilization market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the in-vitro fertilization industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, see saw analysis, and porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global in-vitro fertilization market:

  • Growing median age of first-time motherhood and declining fertility rates are fuelling growth in global in-vitro fertilization market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Technology segment is dominating the market due to growing incidences of male infertility growing adoption of intra-cytoplasmic sperm injection.
  • The embryo culture is the major segment of product segment.
  • Acquisition is the key strategy adopted by the various market players of global in-vitro fertilization market.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL INVITRO FERTILIZATION MAREKT : EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. TOTAL MARKET ANALYSIS

2.4.1.        TOP 5 FINDINGS

2.4.2.        TOP 5 OPPORTUNITY MARKETS

2.4.3.        TOP 5 COMPANIES

2.4.4.        TOP 3 COMPETITIVE STRATEGIES

2.5. ESTIMATION ANALYSIS

2.6. STRATEGIC ANALYSIS

2.6.1.        INVESTMENT VS. ADOPTION MODEL

2.6.2.        360-DEGREE INDUSTRY ANALYSIS

2.6.3.        PORTERS 5 FORCE MODEL

2.6.4.        SEE-SAW ANALYSIS

2.6.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.7. COMPETITIVE ANALYSIS

2.7.1.        KEY STRATEGIES & ANALYSIS

2.7.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.8.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.8.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.8.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        INCREASING RATE OF INFERTILITY ACROSS THE GLOBE

3.1.2.         SURGING PROMOTION OF FERTILITY TOURISM

3.1.3.         INCREASING ADOPTION OF SURROGACY TECHNIQUES

3.1.4.         HIGH SUCCESS RATES OF ADVANCED INVITRO FERTILIZATION TREATMENTS

3.2. MARKET RESTRAINTS

3.2.1.        HIGH COST ASSOCIATED WITH INVITRO FERTILIZATION

3.2.2.         STRINGENT GOVERNMENT REGULATIONS AND ETHICAL CONCERNS

3.3. MARKET OPPORTUNITIES

3.3.1.        INCREASING DEMAND OF LOW COST DEVICES AND DRUGS IN IVF

3.3.2.         SURGING INVESTMENTS BY PRIVATE EQUITY INVESTORS IN IVF 

3.4. MARKET CHALLENGES

3.4.1.        COST BARRIER FOR LOCALS IN EMERGING ECONOMIES

3.4.2.         LOW ACCEPTANCE OF INFERTILITY TREATMENT AMONGST SOCIETY

4.       GLOBAL INVITRO FERTILIZATION MARKET BY PRODUCTS

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL REAGENT PRODUCTS  MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  KEY PLAYERS & KEY PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.2.      GLOBAL EQUIPMENT’S PRODUCTS MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  KEY PLAYERS & KEY PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

5.      GLOBAL INVITRO FERTILIZATION MARKET BY TECHNOLOGY

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.      GLOBAL INTRA-CYTOPLASMIC SPERM INJECTION (ICSI) TECHNOLOGY MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  KEY PLAYERS & KEY PRODUCTS

5.5.1.4.  KEY CONCLUSIONS

5.5.2.      GLOBAL PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD)TECHNOLOGY MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  KEY PLAYERS & KEY PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

5.5.3.      GLOBAL FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) TECHNOLOGY MARKET

5.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.3.  KEY PLAYERS & KEY PRODUCTS

5.5.3.4.  KEY CONCLUSIONS

5.5.3.5.  GLOBAL OTHERS TECHNOLOGY MARKET

5.5.3.6.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.7.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.8.  KEY PLAYERS & KEY PRODUCTS

5.5.3.9.  KEY CONCLUSIONS

5.6. GLOBAL INVITRO FERTILIZATION MARKET BY END USER

5.7. MARKET DEFINITION AND SCOPE

5.8. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.9. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.10.                   OPPORTUNITY MATRIX

5.11.                  MARKET SEGMENTATION

5.11.1.  GLOBAL FERTILITY AND SURGICAL CENTERS END USER MARKET

5.11.1.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

5.11.1.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.11.1.3.                      KEY PLAYERS & KEY PRODUCTS

5.11.1.4.                      KEY CONCLUSIONS

5.11.2.   GLOBAL HOSPITALS AND RESEARCH LABORATORIES TECHNOLOGY END USER MARKET

5.11.2.1.                      ADOPTION SCENARIO & MARKET DETERMINANTS

5.11.2.2.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.11.2.3.                      KEY PLAYERS & KEY PRODUCTS

5.11.2.4.                      KEY CONCLUSIONS

6.       COMPETITIVE LANDSCAPE

6.1. KEY STRATEGIES

6.1.1.        LIST OF MERGERS AND ACQUISITION

6.1.2.        LIST OF JOINT VENTURES

6.1.3.        LIST OF PRODUCT LAUNCHES

6.1.4.        LIST OF PARTNERSHIPS

7.       GEOGRAPHIC ANALYSIS

7.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

7.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

7.3. OPPORTUNITY MATRIX

7.4.                      GLOBAL INVITRO FERTILIZATION (IVF) MARKET BY REGION 2015-2024  

7.4.1.      NORTH AMERICA

7.4.1.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

7.4.1.2.  TOP COUNTRY ANALYSIS

7.4.1.2.1.      U.S.

7.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.1.2.1.2.   KEY PLAYERS & KEY PRODUCTS

7.4.1.2.1.3.   KEY CONCLUSIONS

7.4.1.2.2.      CANADA

7.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.1.2.2.2.   KEY PLAYERS & KEY PRODUCTS

7.4.1.2.2.3.   KEY CONCLUSIONS

7.4.2.      EUROPE

7.4.2.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

7.4.2.2.  TOP COUNTRY ANALYSIS

7.4.2.2.1.      UK

7.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.1.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.1.3.   KEY CONCLUSIONS

7.4.2.2.2.      FRANCE

7.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.2.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.2.3.   KEY CONCLUSIONS

7.4.2.2.3.      GERMANY

7.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.3.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.3.3.   KEY CONCLUSIONS

7.4.2.2.4.      SPAIN

7.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.4.2.   KEY PLAYERS & KEY PRODUCTS

7.4.2.2.4.3.   KEY CONCLUSIONS

7.4.2.2.5.      REST OF EUROPE

7.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.2.2.5.2.   KEY  PLAYERS & KEY PRODUCTS

7.4.2.2.5.3.   KEY CONCLUSIONS

7.4.3.      ASIA PACIFIC

7.4.3.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

7.4.3.2.  TOP COUNTRY ANALYSIS

7.4.3.2.1.      CHINA

7.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.1.2.   KEY PLAYERS & KEY PRODUCTS

7.4.3.2.1.3.   KEY CONCLUSIONS

7.4.3.2.2.      INDIA

7.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.2.2.   KEY PLAYERS & KEY PRODUCTS

7.4.3.2.2.3.   KEY CONCLUSIONS

7.4.3.2.3.      JAPAN

7.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.3.2.   KEY PLAYERS & KEY PRODUCTS

7.4.3.2.3.3.   KEY CONCLUSIONS

7.4.3.2.4.      AUSTRALIA

7.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.4.2.   KEY  PLAYERS & KEY PRODUCTS

7.4.3.2.4.3.   KEY CONCLUSIONS

7.4.3.2.5.      REST OF ASIA PACIFIC

7.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.3.2.5.2.   KEY  PLAYERS & KEY PRODUCTS

7.4.3.2.5.3.   KEY CONCLUSIONS

7.4.4.      ROW

7.4.4.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

7.4.4.2.  TOP COUNTRY ANALYSIS

7.4.4.2.1.      LATIN AMERICA

7.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.4.2.1.2.   KEY PLAYERS & KEY PRODUCTS

7.4.4.2.1.3.   KEY CONCLUSIONS

7.4.4.2.2.      MIDDLE EAST & AFRICA

7.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.4.4.2.2.2.   KEY PLAYERS & KEY PRODUCTS

7.4.4.2.2.3.   KEY CONCLUSIONS

8.       COMPANY PROFILES

8.1. ANDROLOGY SOLUTIONS. (U.K) 

8.1.1.        OVERVIEW

8.1.2.        PRODUCT PORTFOLIO

8.1.3.        STRATEGIC INITIATIVES

8.1.4.        SCOT ANALYSIS

8.1.5.        STRATEGIC ANALYSIS

 

8.2. AUXILIUM PHARMACEUTICALS (IERLAND)

8.2.1.        OVERVIEW

8.2.2.        PRODUCT PORTFOLIO

8.2.3.        STRATEGIC INITIATIVES

8.2.4.        SCOT ANALYSIS

8.2.5.        STRATEGIC ANALYSIS

8.3. AUXOGYN

8.3.1.        OVERVIEW

8.3.2.        PRODUCT PORTFOLIO

8.3.3.        STRATEGIC INITIATIVES

8.3.4.        SCOT ANALYSIS

8.3.5.        STRATEGIC ANALYSIS

8.4. COOPERSURGICAL, INC. (U.S)

8.4.1.        OVERVIEW

8.4.2.        PRODUCT PORTFOLIO

8.4.3.        STRATEGIC INITIATIVES

8.4.4.        SCOT ANALYSIS

8.4.5.        STRATEGIC ANALYSIS

 

8.5. COOK MEDICAL, INC.

8.5.1.1.  OVERVIEW

8.5.1.2.  PRODUCT PORTFOLIO

8.5.1.3.  STRATEGIC INITIATIVES

8.5.1.4.  SCOT ANALYSIS

8.5.1.5.  STRATEGIC ANALYSIS

8.6. FERRING PHARMACEUTICALS (SIWTZERLAND)

8.6.1.        OVERVIEW

8.6.2.        PRODUCT PORTFOLIO

8.6.3.        STRATEGIC INITIATIVES

8.6.4.        SCOT ANALYSIS

8.6.5.        STRATEGIC ANALYSIS

8.7. GENEA. (AUSTRALIA)

8.7.1.        OVERVIEW

8.7.2.        PRODUCT PORTFOLIO

8.7.3.        STRATEGIC INITIATIVES

8.7.4.        SCOT ANALYSIS

8.7.5.        STRATEGIC ANALYSIS

8.8. HALOTECH DNA. OVERVIEW (SPAIN)

8.8.1.        OVERVIEW

 

8.8.2.        PRODUCT PORTFOLIO

8.8.3.        STRATEGIC INITIATIVES

8.8.4.        SCOT ANALYSIS

8.8.5.        STRATEGIC ANALYSIS

8.9. IRVINE SCIENTIFIC. (U.S)

8.9.1.        OVERVIEW

8.9.2.        PRODUCT PORTFOLIO

8.9.3.        STRATEGIC INITIATIVES

8.9.4.        SCOT ANALYSIS

8.9.5.        STRATEGIC ANALYSIS

8.10.                  OVASCIENCE.

8.10.1.   OVERVIEW

8.10.2.   PRODUCT PORTFOLIO

8.10.3.   STRATEGIC INITIATIVES

8.10.4.   SCOT ANALYSIS

8.10.5.   STRATEGIC ANALYSIS

 

8.11.                  MERCK SERONO

8.11.1.   OVERVIEW (GERMANY)

8.11.2.   PRODUCT PORTFOLIO

8.11.3.   STRATEGIC INITIATIVES

8.11.4.   SCOT ANALYSIS

8.11.5.   STRATEGIC ANALYSIS

8.12.                  THERMO FISHER SCIENTIFIC, INC.( U.S)

8.12.1.   OVERVIEW

8.12.2.   PRODUCT PORTFOLIO

8.12.3.   STRATEGIC INITIATIVES

8.12.4.   SCOT ANALYSIS

8.12.5.   STRATEGIC ANALYSIS

8.13.                  THE BAKER COMPANY, INC. (U.S)

8.13.1.   OVERVIEW

8.13.2.   PRODUCT PORTFOLIO

8.13.3.   STRATEGIC INITIATIVES

8.13.4.   SCOT ANALYSIS

8.13.5.   STRATEGIC ANALYSIS

8.14.                  VITROLIFE AB (SWEDEN)

8.14.1.   OVERVIEW

8.14.2.   PRODUCT PORTFOLIO

8.14.3.   STRATEGIC INITIATIVES

8.14.4.   SCOT ANALYSIS

8.14.5.   STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

2.       GLOBAL GLOBAL REAGENT PRODUCTS  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL EQUIPMENT’S PRODUCTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

5.       GLOBAL GLOBAL INTRA-CYTOPLASMIC SPERM  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL INJECTION (ICSI) TECHNOLOGY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7.        GLOBAL PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD)TECHNOLOGY MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) TECHNOLOGY MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL OTHERS TECHNOLOGY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL INVITRO FERTILIZATION MARKET BY END USER 2015-2024 ($ MILLION)

11.   GLOBAL FERTILITY AND SURGICAL CENTERS END USER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL HOSPITALS AND RESEARCH LABORATORIES TECHNOLOGY END USER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   NORTH INVITRO FERTILIZATION (IVF)  MARKET 2015-2024 ($ MILLION)

14.   EUROPE INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

15.   ASIA PACIFIC INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

16.   REST OF THE WORLD INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

17.   NORTH AMERICA INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

18.   EUROPE INVITRO FERTILIZATION MARKET BY PRODUCTS2015-2024 ($ MILLION)

19.   ASIA PACIFIC INVITRO FERTILIZATION MARKET BY PRODUCTS2015-2024 ($ MILLION)

20.   REST OF THE WORLD INVITRO FERTILIZATION MARKET BY PRODUCTS2015-2024 ($ MILLION)

21.   NORTH AMERICA INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

22.   EUROPE FINTECH INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

23.   ASIA PACIFIC INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

24.   REST OF THE WORLD INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

25.   NORTH AMERICA INVITRO FERTILIZATION MARKET BY END USER 2015-2024 ($ MILLION)

26.   EUROPE INVITRO FERTILIZATION MARKET BY END USER 2015-2024 ($ MILLION)

27.   ASIA PACIFIC INVITRO FERTILIZATION MARKET BY END USER 2015-2024 ($ MILLION)

28.   REST OF THE WORLD INVITRO FERTILIZATION MARKET BY END USER 2015-2024 ($ MILLION)

29.   UNITED STATES INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

30.   UNITED STATES INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

31.   UNITED STATES INVITRO FERTILIZATION MARKET BY END USER 2015-2024 ($ MILLION)

32.   CANADA INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

33.   CANADA INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

34.   CANADA INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

35.   UK INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

36.   UK INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

37.   UK INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

38.   FRANCE INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

39.   FRANCE INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

40.   FRANCE INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

41.   GERMANY INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

42.   GERMANY INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

43.   GERMANY INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

44.   SPAIN INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

45.   SPAIN INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

46.   SPAIN INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

47.   ROE INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

48.   ROE INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

49.   ROE INVITRO FERTILIZATION MARKET BY END USER   2015-2024 ($ MILLION)

50.   CHINA INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

51.   CHINA INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

52.   CHINA INVITRO FERTILIZATION MARKET BY END USER   2015-2024 ($ MILLION)

53.   INDIA INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

54.   INDIA INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

55.   INDIA INVITRO FERTILIZATION MARKET BY END USER   2015-2024 ($ MILLION)

56.   JAPAN INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

57.   JAPAN INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

58.   JAPAN INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

59.   AUSTRALIA INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

60.   AUSTRALIA INVITRO FERTILIZATION MARKET BY TECHNOLOGY SIZE 2015-2024 ($ MILLION)

61.   AUSTRALIA INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

62.   ROAPAC INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

63.   ROAPAC INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

64.   ROAPAC INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

65.   LATIN INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

66.   LATIN AMERICA INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

67.   LATIN INVITRO FERTILIZATION MARKET BY END USER  2015-2024 ($ MILLION)

68.   MENA INVITRO FERTILIZATION MARKET BY PRODUCTS 2015-2024 ($ MILLION)

69.   MENA INVITRO FERTILIZATION MARKET BY TECHNOLOGY 2015-2024 ($ MILLION)

70.   MENA INVITRO FERTILIZATION MARKET BY END USER 2015-2024 ($ MILLION)

 

LIST OF FIGURES

1.       GLOBAL REAGENT PRODUCTS  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

2.       GLOBAL EQUIPMENT’S PRODUCTS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL INTRA-CYTOPLASMIC SPERM  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL INJECTION (ICSI) TECHNOLOGY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.        GLOBAL PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD)TECHNOLOGY MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) TECHNOLOGY MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

7.       GLOBAL OTHERS TECHNOLOGY MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL FERTILITY AND SURGICAL CENTERS END USER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL HOSPITALS AND RESEARCH LABORATORIES TECHNOLOGY END USER MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   UNITED STATES (U.S.) INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

11.   CANADA INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

12.   UNITED KINGDOM (UK) INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

13.   FRANCE INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

14.   GERMANY INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

15.   SPAIN INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

16.   ROE INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

17.   CHINA INVITRO FERTILIZATION (IVF) 2015-2024 ($ MILLION)

18.   INDIA INVITRO FERTILIZATION (IVF) 2015-2024 ($ MILLION)

19.   JAPAN INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

20.   AUSTRALIA INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

21.   ROAPAC INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

22.   LATIN AMERICA INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION)

23.   MENA INVITRO FERTILIZATION (IVF) MARKET 2015-2024 ($ MILLION) 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion